Inter-observer variation of p53 immunohistochemistry - An assessment of a practical problem and comparison with other studies

British Journal of Biomedical Science

Volumn 53, Issue 2, 1996, Pages 101-107

  Kay, E W ^a  

^a BEAUMONT HOSPITAL   (Ireland)

Author keywords

Carcinoma; Immunochemistry; Immunologic techniques

Indexed keywords

PROTEIN P53;

ARTICLE; COLORECTAL CARCINOMA; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; OBSERVER VARIATION; PRIORITY JOURNAL; SKIN CARCINOMA; SQUAMOUS CELL CARCINOMA; TRANSITIONAL CELL CARCINOMA; UTERINE CERVIX CARCINOMA IN SITU;

FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; NEOPLASM PROTEINS; NEOPLASMS; OBSERVER VARIATION; TUMOR MARKERS, BIOLOGICAL; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0029957381     PISSN: 09674845     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (3)

1. Donehower LA, Harvey M, Slagle BL et al. Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours. Nature 1992; 346:215-21.
2. Malkin D, Li FP, Strong LC et al. Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas and other neoplasms. Science 1990; 250:1233-8.
3. Lane DP, Benchimol S. p53: oncogene or anti-oncogene? Genes Dev 1990; 4:1-8.